ETS1 and metastatic malignant neoplasm in the lymph nodes: In pancreatic carcinomas, ETS1 expression has no association with the lymph node metastasis, tumor size, prognosis, or tumor-node-metastasis stage [2], while in colorectal carcinoma, it correlated with the lymph node metastasis, the depth grading of tumor invasion, as well as its invasion into the lymphatic or venous vessel [9].